Inderm Lotion

Erythromycin, the active ingredient in Inderm Lotion, is a macrolide antibiotic presented as a lotion for topical use. It treats acne vulgaris and bacterial skin infections by delivering a localized antimicrobial effect to the skin of patients of all ages.

GNH USA supplies Inderm Lotion as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide, with distribution channels that meet EU regulatory standards and support global procurement needs.

Erythromycin lotion is a topical macrolide antibiotic used to manage bacterial skin conditions.

Acne vulgaris: reduces inflammatory lesions and bacterial colonisation. Folliculitis: clears infection of hair follicles caused by susceptible bacteria. Other bacterial skin infections: treats localized infections such as impetigo caused by erythromycin‑sensitive organisms.

Topical erythromycin may cause a range of skin‑related adverse reactions.

Common Side Effects: - Skin irritation: mild burning or stinging at the application site. - Itching (pruritus): localized discomfort. - Dryness or flaking of the skin. - Redness (erythema) around the treated area. - Contact dermatitis: allergic skin reaction. - Peeling or scaling.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rapid swelling, difficulty breathing. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: extensive skin blistering. - Photosensitivity: heightened skin reaction to sunlight. - Drug eruption: widespread rash. - Development of resistant bacterial strains with prolonged use.

When using Inderm Lotion, consider the following safety measures.

Assess for hypersensitivity: avoid use in patients with known erythromycin allergy. Limit duration: prolonged use may promote bacterial resistance. Avoid on extensive skin damage: do not apply to open wounds unless specifically directed. Use with caution in pregnancy: consult a healthcare professional before use. Avoid concurrent use with other topical antibiotics unless instructed. Store at room temperature: keep in the original container, protect from light and moisture.

Topical erythromycin can interact with other medications, primarily when systemic absorption is possible.

Major Interactions (Avoid): - Concurrent systemic macrolide therapy: may increase risk of additive toxicity and promote resistance. - Oral erythromycin: simultaneous use can lead to unnecessary duplication of therapy.

Moderate Interactions (Monitor Closely): - Cytochrome P450 inhibitors (e.g., clarithromycin, ketoconazole): may raise systemic levels if large skin areas are treated. - Other topical antibiotics: monitor for overlapping toxicity or resistance development. - Antifungal agents applied to the same area: assess for potential irritation.